Teams consisting of
at least two non-profit
patient and/or medical
groups submit an
concept to engage
people in their health.
select four teams whose
concepts illustrate a
could only be possible
through their teams’
Four finalist teams
$25,000 and access
to mentors to
help hone their
Four finalist teams
refined concept, and
to the judges at
an event in
One winning team is
awarded $300,000, and
one runner-up team is
In addition, both teams
will be offered the
opportunity to access
Sanofi US resources.
Collaborate | Activate is the first innovation challenge rooted in the idea that patient advocates working together can develop a deeper understanding of healthcare issues and magnify their collective impact on people’s health. Collaborate | Activate promotes patient-centered solutions that could only emerge through the cross-pollination and collaboration of the partnering organizations. Regardless of whether the concept is a high-touch solution or a simple intervention that can create impact at scale, Collaborate | Activate is focused on motivating people to become more engaged in their health.Submitted concepts will be evaluated on the following criteria:
Sanofi US believes that better approaches and solutions to engaging people in their health can be created by encouraging collaboration among patient advocates. For the 2012 Collaborate | Activate Innovation Challenge, collaborations among two or more organizations (non-profit patient and/or medical professional advocacy groups) that yield exceptional solutions will be recognized by an independently selected panel of judges and rewarded in the following ways:
No Purchase Necessary
Sponsored by sanofi-aventis US, 55 Corporate Dr., Bridgewater, NJ 08807 (“Sponsor”). Void where prohibited. All entrants agree to be bound by these Official Rules.
The Collaborate | Activate Innovation Challenge (“Competition”, “Contest” or “Innovation Challenge”) is open to non-profit patient advocacy groups or medical professional organizations with designated non-profit status and good standing. Submissions from 2 or more organizations working in collaboration are accepted. Employees, officers and directors of Sponsor and any of its affiliates, agents, parent or subsidiary companies and advertising and promotion agencies, and members of their immediate families (spouses, parents, children, and siblings and their spouses) and/or those living in the same household of each (whether or not related) are not eligible to participate. By participating, you agree to these Official Rules and the decisions of Sponsor, which are final and binding in all respects. Void outside of the 50 United States and the District of Columbia, and where prohibited, taxed or restricted by law. All federal, state and local laws and regulations apply.
Submissions for the Competition can be made beginning 12:01am EST July 23, 2012, until August 31, 2012, at 11:59pm EST. Sponsor will announce four finalist teams on www.collaborateactivate.com (the “Website”) on September 17, 2012, and each finalist team will receive an e-mail notification. The four finalists will be provided with mentorship from selected business, technology, public health, and design advocates who will help evolve the concept into an implementation plan during September and October 2012. Finalists will take part in a “Finalist Event” on October 29, 2012 in the Washington, D.C. Metropolitan area. Videos of the Finalist Event presentations will be streamed to the Website. Sponsor will announce one winner and one runner-up on the Website on November 15, 2012.
(A) To Enter: Access the Website and complete the information fields; specifically, team primary and secondary name and email addresses, partnering organization names and websites, 3 team collaboration questions, 4 concept detail questions, and optional visual media.
All entry information and submissions, including team and concept details, shall be collectively referred to herein as the “Submissions” or each as a “Submission.” Prior to uploading your Submission, you must also affirmatively confirm that you have read, understand and agree to these Official Rules by clicking on the check box on the Submission form.
(B) Submission: Each Submission must consist of one (1) textual submission and an optional one (1) visual asset. Submit your own original Submission to the submission page on the Website. Text submissions may be accompanied by some type of visual media describing the proposed concept: a diagram, screenshot, doodle, a wireframe, or similar schematic.
(C) Submission Parameters: Submissions (i) must be the 100% original and sole creation of the entrant, and all right, title and interest, including but not limited to the copyright in any Submission, must be owned solely by the submitting entrant, (ii) may not have been submitted in any other competition prior or subsequent to the date of entry into this Promotion, (iii) may not have been published anywhere prior to the date of entry into this Promotion, (iv) may not infringe upon any third party’s rights, including but not limited to copyright, patent or trademarks/tradenames/logos, or rights of privacy or publicity, or contain material that is or may be considered defamatory, slanderous or libelous, or portray or depict any person, product or entity in a false light, (v) must be truthful and accurate in all respects, (vi) may not violate any law, rule or regulation, (vii) may not contain any virus, bugs or other deleterious material, and (viii) may not contain or depict, for example but not limited to, profanity, defamatory statements, words or symbols widely considered offensive to individuals of any certain race, ethnicity, religious, sexual orientation or socioeconomic group, threats to any person, place, business, group or world peace; and each entrant warrants and represents that his/her Submission complies with all of those conditions. Submissions cannot contain, among other things, the trademark, tradename or logo of any third party or entity or product (including but not limited to the trademark, tradename or logo of any product competitive with any product of Sponsor, and including, but not limited to, on clothing), cannot contain, name, depict or describe any person (living, dead or fictional) other than the entrant and cannot contain any material that is protected by copyright. Any non-complying Submission with these Official Rules will be subject to disqualification. By entering, each Entrant grants permission for the use of his/her Submission, and his/her name, and likeness, to be posted on the Internet (including the Website) in connection with this Challenge, and the advertising, promotion, and publicity of the Challenge, and otherwise, as stated in these Official Rules (as solely determined by Sponsor); and each Entrant warrants and represents that he/she has all right and authority to grant such permission. Notwithstanding anything to the contrary, however, there is no obligation of the Sponsor or any other person or entity to post or make any use of the Submission of any particular Entrant, or of any Entrant’s information.
(D) Conditions of Submission: Only fully completed entry forms are eligible. Proof of submission will not be deemed to be proof of receipt by Sponsor. Notwithstanding anything to the contrary, Sponsor reserves the right to disqualify any Submission that Sponsor, in its sole opinion, deems inappropriate. Questions concerning the Challenge will not be acknowledged or responded to, but technical questions only, for example, that may involve the inability to access the Website, or the inability to attach a visual asset to the Submission, can be sent to email@example.com. Submissions that do not conform to these Official Rules or are submitted in any manner other than stated in these Official Rules will be disqualified.
(A) Judging Phase: As Submissions are received, all eligible Submissions will be judged by a panel of judges determined by Sponsor to have the required knowledge and experience to apply the judging criteria, and may include: a Sanofi senior executive, a foundation representative, public health expert, medical professional, managed health system executive, prominent patient advocate, healthcare innovation leader. Judging will be based and scored on the following judging criteria and stated point availability for each criterion: (i) Ability of the proposed concept to enable patients to take more control of their health and wellbeing in a way that is differentiated from other solutions in the marketplace (up to 40 points); (ii) Illustration of how patient insights, healthcare resources, professional experiences, and methodologies shared across the collaborating organizations informed the concept development (up to 30 points); (iii) Potential of the collaborating teams to demonstrate influence or impact on patient health through the metrics and measurements of success associated with their concept and implementation plan (up to 30 points). Subject to verification and compliance with these Official Rules, the four (4) entrant teams with the highest scoring Submissions will be selected as finalists on September 17, 2012. When notification of the finalist teams is completed, or as soon as is practical thereafter, the Submissions selected by the finalist teams will be listed on the Website for public viewing. THE JUDGING SCORES WILL NOT BE POSTED OR OTHERWISE AVAILABLE. Each of the four finalist teams will receive one-on-one mentorship to further develop their concept into a plan. Mentorship will also be provided to help strengthen their cross-organization collaboration. On October 29, 2012, the four finalist teams will present their plans to the judges in a Finalist Event in the Washington, D.C. Metropolitan area. The judges will evaluate each of the presentations and plans. One (1) winning team and one (1) runner-up team will be announced on November 15, 2012.
Representatives of the selected finalist teams must be able to attend and present at Finalist Event on October 29, 2012. If representatives from the finalist team are unable to attend, they will not be considered for the next round, and they forfeit their award monies. The Sponsor will provide a stipend to the finalist teams to defray reasonable transportation and travel costs to the Finalist Event.
NO PURCHASE NECESSARY. NO WRITTEN RESPONSE NECESSARY. A PURCHASE OR PARTICULAR RESPONSE DOES NOT IMPROVE YOUR CHANCE OF WINNING. VOID WHERE PROHIBITED. ODDS OF WINNING DEPEND ON NUMBER OF ELIGIBLE ENTRIES RECEIVED AND DETERMINATION OF JUDGES.
Sanofi US reserves the right to suspend, postpone, cease, terminate or otherwise modify the Innovation Challenge at any time, without assigning any reason, at its sole option and discretion and Sanofi US shall have no liability, whatsoever, in any such event.
Any individual or team that submits an entry to the Innovation Challenge (“Entrant”) selected as a finalist must comply with all terms and conditions set forth in these Official Rules, and winning is contingent upon fulfilling all requirements. Finalists will be selected by a panel of judges. The Challenge will occur under the guidance of Sanofi US. Entrants agree to be bound by these rules and the decision of the judges, whose decisions are final.
Potential finalist teams will be notified by e-mail by September 14, 2012. Potential runner-up and winner teams will be notified by e-mail by November 12, 2012. If a potential finalist, runner-up, or winner team cannot be contacted and does not reply with appropriate affidavit and contact information within three (3) days after the first attempt to contact such potential finalist, runner-up, or winner, an alternate entrant team will be selected in their place based on score and judges’ discretion. Should a finalist team drop-out or be determined ineligible, the judges may select an alternate based on scoring and at their discretion, to encourage diversity of projects.
The following prizes will be awarded to 4 finalist teams: (1) $25,000 to further shape their collaborative concept, (2) mentorship to hone their collaboration and concept strategy. From these 4 finalist teams, 1 winning team will be selected and receive: (1) $300,000, (2) the opportunity to access additional expertise and resources (nonmonetary) through Sanofi US to further evolve and develop their plan. From these 4 finalist teams, 1 runner-up team will be selected and receive: (1) $100,000, (2) the opportunity to access additional expertise and resources (nonmonetary) through Sanofi US to further evolve and develop their plan. Odds of winning dependent upon number of entries submitted and strength of entry based on the judgment of the judges.
Total estimated retail value of all prizes is $500,000. There will be no substitutions for prizes. Prizes awarded are non-transferable and may not be exchanged or redeemed for cash, sold, or traded. Sponsor reserves the right to substitute a prize, in which case a prize of equal or greater value will be awarded.
Materials submitted may be published in the public domain, royalty-free, by the Challenge organizers, in conjunction with promotions of this competition. All efforts on the part of Sanofi US will be in good faith to maintain correct acknowledgment of the submitter. Sanofi US will not make the content of the submissions available to any outside party except the Panel of Judges of the contest. Please NOTE: entrants retain full intellectual property (“IP”) rights to their submitted concepts.
In the event of a dispute, entries made by Internet will be deemed made by the authorized account holder of the e-mail address submitted at the time of entry. The “authorized account holder” is deemed the natural person who is assigned to an e-mail address by an Internet access provider, service provider or other online organization that is responsible for assigning e-mail addresses for the domain associated with the submitted e-mail address. A potential winner may be requested to provide Sanofi US with proof that the potential winner is the authorized account holder of the e-mail address associated with the winning entry. If for any reason the Challenge is not capable of running as planned, including due to infection by computer virus, bugs, tampering, unauthorized intervention, fraud, technical failure, human error or any other causes beyond the control of Sanofi US that corrupt or affect the administration, security, fairness, integrity, or proper conduct of the Challenge, Sanofi US reserves the right in their sole discretion, to disqualify any individual who tampers with the entry process, and to cancel, terminate, modify or suspend the Challenge. Sanofi US assumes no responsibility for any error, omission, interruption, deletion, defect, delay in operation or transmission, communications line failure, theft or destruction or unauthorized access to, or alteration of, entries. Sanofi US is not responsible for any problems or technical malfunction of any, computer online systems, servers, or providers, computer equipment, software, failure of any e-mail or entry to be received by Sanofi US on account of technical problems or traffic congestion on the Internet or at any web site, any combination thereof, or otherwise, including any injury or damage to entrant's or any other person's computer related to or resulting from participation or downloading any materials in the Challenge. Sanofi US is not responsible for late, lost, illegible, incomplete, stolen, or misdirected entries. CAUTION: ANY ATTEMPT BY AN ENTRANT TO DELIBERATELY DAMAGE ANY WEB SITE OR UNDERMINE THE LEGITIMATE OPERATION OF THE Challenge MAY BE A VIOLATION OF CRIMINAL AND CIVIL LAWS AND SHOULD SUCH AN ATTEMPT BE MADE, SANOFI US RESERVES THE RIGHT TO SEEK DAMAGES FROM ANY SUCH PERSON TO THE FULLEST EXTENT PERMITTED BY LAW.
DISPUTE RESOLUTION/CHOICE OF LAW: Except where prohibited, each entrant agrees that: (1) any and all disputes, claims and causes of action arising out of or connected with this Promotion shall be resolved individually, without resort to any form of class action, and exclusively by the United States District Court or the appropriate State Court located in New York; (2) any and all claims, judgments and awards shall be limited to actual out-of-pocket costs incurred, including costs associated with participating in this Promotion, but in no event attorneys’ fees; and (3) under no circumstances will participant be permitted to obtain awards for, and participant hereby waives all rights to claim, indirect, punitive, incidental and consequential damages and any other damages, other than for actual out-of-pocket expenses, and any and all rights to have damages multiplied or otherwise increased.
All issues and questions concerning the construction, validity, interpretation and enforceability of these Official Rules, or the rights and obligations of the participant and Releases in connection with the Promotion, shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect to any choice of law or conflict of law rules (whether of the State of New Jersey or any other jurisdiction), which would cause the application of the laws of any jurisdiction other than the State of New York.
SPONSOR: sanofi-aventis US, 55 Corporate Drive, Bridgewater, NJ 08807
July 23, 2012 – Competition announced and open submissions accepted via the Collaborate | Activate website.
August 31, 2012 – Last day to submit an entry.
September 17, 2012 – Four finalist teams announced and awarded $25,000 each.
September - October 2012 – Four finalist teams receive mentorship to transform their concepts into implementation plans.
November 19, 2012 (updated) – Four finalist teams present their refined concepts and implementation plans to the judges during the Finalist Event in the Washington, DC metropolitan area. Videos of the Finalist Event will be streamed on the website.
December 12, 2012 (updated) – From the four finalist teams, one winning team is announced and awarded $300,000. One runner-up team is awarded $100,000. Both the winning team and the runner-up teams will be offered the opportunity to access Sanofi US resources to further develop their plans.
All intellectual property and equity will remain the property of its creators throughout the entire competition. Please review the Rules and Terms & Conditions..
Please confirm your email address.